Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on May 6, 2025
AMRT Satellite Technology Uncovers Significant Mineral Assets at Historic Oregon Mine
EIN Presswire
·
May 6, 2025
Abandoned Mine Expected to Roar Back to Life with Massive Results thanks to AMRT Satellite Scan Technology MESA, AZ, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- CC Explorations, a leading satellite-based mineral exploration company, today announced …
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …
Pacira BioSciences to Present 3-Year Safety and Efficacy Data of PCRX-201 Following Single Intra-Articular Injection for Moderate-to-Severe Knee Osteoarthritis
GlobeNewswire
·
May 6, 2025
-- Data will be featured at EULAR Annual Congress – BRISBANE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of …
Avalyn Announces Multiple Presentations on AP01 and AP02 for Pulmonary Fibrosis at the American Thoracic Society 2025 International Conference
GlobeNewswire
·
May 6, 2025
Topline Results from the AP02 (Inhaled Nintedanib) Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be …
Scality expands distribution with Ingram Micro in ANZ and the South Pacific region
GlobeNewswire
·
May 6, 2025
SAN FRANCISCO, May 06, 2025 (GLOBE NEWSWIRE) -- Scality, a global leader in cyber-resilient storage software for the AI era, announced today the expansion of its distribution network with Ingram Micro in Australia, New Zealand, and the South Pacific region …
Chuck Cory Appointed to Weave.AI Board of Directors
GlobeNewswire
·
May 6, 2025
SEATTLE, May 06, 2025 (GLOBE NEWSWIRE) -- Weave.AI today announced the appointment of Chuck Cory to its Board of Directors. A veteran of the technology and investment banking sectors, Cory brings over three decades of experience advising some of the world’ …
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
GlobeNewswire
·
May 6, 2025
MORRISVILLE, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company’s Chief Financial Officer …
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
May 6, 2025
Dose optimization and RP2D determination on schedule for completion in Q4 2025 for the Nectin-4 ADC CRB-701 in HNSCC, cervical and mUC tumors SAD/MAD study on schedule for completion in Q3 2025 for the anti-obesity CB1 inverse agonist CRB-913 Dose …
Vertex Study: Global Tax and Finance Leaders Significantly Shift in Support of e-Invoicing
GlobeNewswire
·
May 6, 2025
KING OF PRUSSIA, Pa., May 06, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced new e-invoicing research revealing that a majority (79%) of global business …
Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire
·
May 6, 2025
ASHBURN, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its …
Cogent Biosciences Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million in …
Uplight Secures Leadership in Guidehouse Home Energy Management Providers Category and Unveils New Demand Stack Activation Engine
GlobeNewswire
·
May 6, 2025
BOULDER, Colo., May 06, 2025 (GLOBE NEWSWIRE) -- Uplight, a clean energy technology company that unlocks grid capacity by activating customers and their connected devices to generate, shift, and save energy, today announced new distinctions received for …
IPG Photonics Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Growth from Strategic Initiatives Drove Revenue Above the Midpoint of Guidance Book-to-Bill was Above One and Highest in Over Two Years MARLBOROUGH, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial …
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, …
Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate
GlobeNewswire
·
May 6, 2025
RESEARCH TRIANGLE PARK, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other ophthalmic …
Actuate Therapeutics Announces Statistically Significant Topline Results from Global Phase 2 Trial of Elraglusib in First-Line Treatment of Metastatic Pancreatic Cancer
GlobeNewswire
·
May 6, 2025
Topline data shows statistically significant improvement in overall survival in elraglusib plus GnP combination arm versus GnP control arm Elraglusib/GnP combination arm demonstrated substantial improvement in median overall survival since the last data …
Vital Battery Metals Appoints Michael Mulberry as Advisor
GlobeNewswire
·
May 6, 2025
VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Vital Battery Metals Inc. (“Vital” or the “Company”) (CSE: VBAM | OTC: VBAMF | FRA: C0O), is pleased to announce the appointment of Michael Mulberry as a technical advisor to the Company (the “ …
Krystal Biotech Announces First Quarter 2025 Financial and Operating Results
GlobeNewswire
·
May 6, 2025
VYJUVEK approved in Europe for the treatment of DEB patients from birth $88.2 million in 1Q VYJUVEK revenue and $429.4 million since launch in Q3 2023 Second ophthalmic program in clinic - KB801 for the treatment of neurotrophic keratitis Upcoming clinical …
Trident Resources Receives Drill Permits for its High-Grade Gold Projects Located in Saskatchewan; Plans for Upcoming Drill Programs
GlobeNewswire
·
May 6, 2025
Vancouver, BC, May 06, 2025 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSXV: ROCK) (OTCQB: EROSD) (“Trident” or the “Company”) is pleased to announce that the Saskatchewan Ministry of Environment has issued two exploration permits for the Contact Lake …
Duos Technologies Group Sets First Quarter 2025 Earnings Call for Thursday, May 15, 2025 at 4:30 PM ET
GlobeNewswire
·
May 6, 2025
JACKSONVILLE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT) will hold a conference call on Thursday, May 15, 2025 at 4:30 p.m. Eastern time to discuss its financial results for the first …